References
- Bjork I, Lindahl U. Mechanism of the anticoagulant action of heparin. Molecular Cell Biochemistry 1982; 48: 161–182
- Brion M, Berthon G, Fourtillan JB. Metal ion-tetracyclines interactions in biological fluids. Potentiometric study of calcium complexes with tetracycline, oxytetracycline, doxycycline, and minocycline and simulation of their distributions under physiological conditions. Inorganica Chimica Acta 1981; 55: 47–56
- Dawidowicz AL, Kalitynski R. Effects of intraoperative fluid infusions, sample storage time, and sample handling on unbound propofol assay in human blood plasma. Journal of Pharmaceutical and Biomedical Analysis 2005; 37: 1167–1171
- Gordon GF, Vance RB. EDTA chelation therapy for atherosclerosis: History and mechanism of action. Osteopathology Annals 1976; 4: 38–62
- Holleman A, Holleman F, Wiberg E. Inorganic chemistry. Academic Press, San Diego, CA 2001
- Jogun KH, Stezowski JJ. Chemical–structural properties of tetracycline derivatives. Journal of the American Chemistry Society 1976; 98: 6018–6026
- Kawai Y, Matsubayashi K, Hakusui H. Interaction of quinolones with metal cations in aqueous solution. Chemistry and Pharmacy Bulletin (Tokyo) 1996; 44: 1425–1430
- MacGowan A, Bowker K. Developments in PK/PD: optimizing efficacy and prevention of resistance. A critical review of PK/PD in in vitro models. International Journal of Antimicrobials and Silver 2002; 19: 291–298
- Martin RB. Tetracyclines and daunomycin. Metal Ions in Biological Systems 1985; 19: 19–52
- Ming LJ. Structure and function of ‘metalloantibiotics’. Medical Research Reviews 2003; 23: 697–762
- Muralidharan G, Micalizzi M, Speth J, Raible D, Troy S. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrobial Agents and Chemotherapy 2005; 49(1)220–229
- Ohyama T, Cowan JA. Calorimetric studies of metal binding to tetracycline. Role of solvent structure in defining the selectivity of metal ion–drug interactions. Inorganic Chemistry 1995; 34: 3083–3068
- Rodriguez-Mendizabal M, Lucena MI, Cabello MR, Blanco E, Lopez-Rodriguez B, De la Cuesta FS. Variations in blood levels of aminoglycosides related to in vitro anticoagulant usage. Therapy and Drug Monitoring 1998; 20: 88–91
- Sadagopan NP, Li W, Cook JA, Galvan B, Weller DL, Fountain ST, Cohen LH. Investigation of EDTA anticoagulant in plasma to improve the throughput of liquid chromatography/tandem mass spectrometric assays. Rapid Communications in Mass Spectrometry 2003; 17: 1065–1070
- Smeraglia J, Baldrey SF, Watson D. Matrix effects and selectivity issues in LC-MS-MS. Chroma 2002; 55(Suppl.)95–99
- Tarasidis CG, Garnett WR, Kline BJ, Pellock JM. Influence of tube type, storage time, and temperature on the total and free concentration of valproic acid. Therapy and Drug Monitoring 1986; 8: 373–376
- Turel I, Leban I, Bukovec N. Synthesis, characterization, and crystal structure of a copper(II) complex with quinolone family member ciprofloxacin. Journal of Inorganic Biochemistry 1994; 56: 273–282
- Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 1999; 58(Suppl. 2)29–36